These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 30344461)

  • 1. Therapeutic Efficacy and Safety of Prolonged Macrolide, Corticosteroid, Doxycycline, and Levofloxacin against Macrolide-Unresponsive
    Ha SG; Oh KJ; Ko KP; Sun YH; Ryoo E; Tchah H; Jeon IS; Kim HJ; Ahn JM; Cho HK
    J Korean Med Sci; 2018 Oct; 33(43):e268. PubMed ID: 30344461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiologic findings as a determinant and no effect of macrolide resistance on clinical course of Mycoplasma pneumoniae pneumonia.
    Yoon IA; Hong KB; Lee HJ; Yun KW; Park JY; Choi YH; Kim WS; Lee H; Eun BW; Ahn YM; Cho EY; Cho HJ; Choi EH
    BMC Infect Dis; 2017 Jun; 17(1):402. PubMed ID: 28592263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges in the treatment of pediatric Mycoplasma pneumoniae pneumonia.
    Ding G; Zhang X; Vinturache A; van Rossum AMC; Yin Y; Zhang Y
    Eur J Pediatr; 2024 Jul; 183(7):3001-3011. PubMed ID: 38634891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of doxycycline therapy for macrolide-resistant Mycoplasma pneumoniae pneumonia in children at different periods.
    Chen Y; Zhang Y; Tang QN; Shi HB
    Ital J Pediatr; 2024 Mar; 50(1):38. PubMed ID: 38439015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An adult case of severe life-threatening Mycoplasma pneumoniae pneumonia due to a macrolide-resistant strain, Japan: a case report.
    Matsumoto M; Nagaoka K; Suzuki M; Konno S; Takahashi K; Takashina T; Ishiguro N; Nishimura M
    BMC Infect Dis; 2019 Feb; 19(1):204. PubMed ID: 30819124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New-generation tetracyclines for severe macrolide-resistant Mycoplasma pneumoniae pneumonia in children: a retrospective analysis.
    Song X; Zhou N; Lu S; Gu C; Qiao X
    BMC Infect Dis; 2024 Oct; 24(1):1166. PubMed ID: 39407159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid defervescence after doxycycline treatment of macrolide-resistant Mycoplasma pneumoniae-associated community-acquired pneumonia in children.
    Lung DC; Yip EK; Lam DS; Que TL
    Pediatr Infect Dis J; 2013 Dec; 32(12):1396-9. PubMed ID: 23817339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children.
    Dai FF; Liu FQ; Chen X; Yang J; Wang K; Guo CY
    J Clin Pharm Ther; 2021 Jun; 46(3):705-710. PubMed ID: 33403672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of levofloxacin on macrolide-unresponsive and corticosteroid-resistant refractory Mycoplasma pneumoniae pneumonia in children.
    Lin M; Shi L; Huang A; Liang D; Ge L; Jin Y
    Ann Palliat Med; 2019 Nov; 8(5):632-639. PubMed ID: 31865723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children.
    Okada T; Morozumi M; Tajima T; Hasegawa M; Sakata H; Ohnari S; Chiba N; Iwata S; Ubukata K
    Clin Infect Dis; 2012 Dec; 55(12):1642-9. PubMed ID: 22972867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annual and seasonal patterns in etiologies of pediatric community-acquired pneumonia due to respiratory viruses and Mycoplasma pneumoniae requiring hospitalization in South Korea.
    Lee E; Kim CH; Lee YJ; Kim HB; Kim BS; Kim HY; Kim Y; Kim S; Park C; Seo JH; Sol IS; Sung M; Song MS; Song DJ; Ahn YM; Oh HL; Yu J; Jung S; Lee KS; Lee JS; Jang GC; Jang YY; Chung EH; Chung HL; Choi SM; Choi YJ; Han MY; Shim JY; Kim JT; Kim CK; Yang HJ;
    BMC Infect Dis; 2020 Feb; 20(1):132. PubMed ID: 32050912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of viral coinfection and macrolide-resistant mycoplasma infection in children with refractory Mycoplasma pneumoniae pneumonia.
    Zhou Y; Wang J; Chen W; Shen N; Tao Y; Zhao R; Luo L; Li B; Cao Q
    BMC Infect Dis; 2020 Aug; 20(1):633. PubMed ID: 32847534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy of macrolide antibiotics against genetically determined macrolide-resistant Mycoplasma pneumoniae pneumonia in paediatric patients.
    Kawai Y; Miyashita N; Yamaguchi T; Saitoh A; Kondoh E; Fujimoto H; Teranishi H; Inoue M; Wakabayashi T; Akaike H; Ogita S; Kawasaki K; Terada K; Kishi F; Ouchi K
    Respirology; 2012 Feb; 17(2):354-62. PubMed ID: 22077195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy of macrolide antibiotics in mycoplasma pneumoniae pneumonia carrying a macrolide-resistant mutation in the 23 S rRNA gene in pediatric patients.
    He M; Xie J; Rui P; Li X; Lai M; Xue H; Chen C
    BMC Infect Dis; 2024 Jul; 24(1):758. PubMed ID: 39085799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe macrolide-resistant Mycoplasma pneumoniae pneumonia associated with macrolide failure.
    Cheong KN; Chiu SS; Chan BW; To KK; Chan EL; Ho PL
    J Microbiol Immunol Infect; 2016 Feb; 49(1):127-30. PubMed ID: 25556047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Efficacy of Antimicrobial Agents Among Hospitalized Patients With Mycoplasma pneumoniae Pneumonia in Japan During Large Epidemics of Macrolide-Resistant M. pneumoniae Infections: A Nationwide Observational Study.
    Tashiro M; Fushimi K; Kawano K; Takazono T; Saijo T; Yamamoto K; Kurihara S; Imamura Y; Miyazaki T; Yanagihara K; Mukae H; Izumikawa K
    Clin Infect Dis; 2017 Nov; 65(11):1837-1842. PubMed ID: 29020161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Efficacy of Doxycycline for Treatment of Macrolide-Resistant
    Lee H; Choi YY; Sohn YJ; Kim YK; Han MS; Yun KW; Kim K; Park JY; Choi JH; Cho EY; Choi EH
    Antibiotics (Basel); 2021 Feb; 10(2):. PubMed ID: 33671151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of tetracyclines and fluoroquinolones for the treatment of macrolide-refractory Mycoplasma pneumoniae pneumonia in children: a systematic review and meta-analysis.
    Ahn JG; Cho HK; Li D; Choi M; Lee J; Eun BW; Jo DS; Park SE; Choi EH; Yang HJ; Kim KH
    BMC Infect Dis; 2021 Sep; 21(1):1003. PubMed ID: 34563128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of hospitalized children infected with macrolide-resistant Mycoplasma pneumoniae.
    Komatsu H; Tsunoda T; Inui A; Sogo T; Fujisawa T
    Braz J Infect Dis; 2014; 18(3):294-9. PubMed ID: 24389284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycoplasma pneumoniae in pediatric patients: Do macrolide-resistance and/or delayed treatment matter?
    Yang TI; Chang TH; Lu CY; Chen JM; Lee PI; Huang LM; Chang LY
    J Microbiol Immunol Infect; 2019 Apr; 52(2):329-335. PubMed ID: 30341022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.